<DOC>
	<DOC>NCT01948648</DOC>
	<brief_summary>If treatment of colesevelam, fish oil in conjunction with ezetimibe, will lead to further reduction in plasma plant sterol levels in sitosterolemia patients. We hypothesize that treatments with fish oil, colesevelam and ezetimibe will maximize decrease in plasma concentrations of sitosterol and other plant sterols in sitosterolemia patients.</brief_summary>
	<brief_title>Effects of Fish Oil and Colesevelam</brief_title>
	<detailed_description />
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Intestinal Diseases</mesh_term>
	<mesh_term>Lipid Metabolism, Inborn Errors</mesh_term>
	<mesh_term>Colesevelam Hydrochloride</mesh_term>
	<criteria>1. Confirmed diagnosis of homozygous sitosterolemia as established by genotyping and/or clinical parameters 2. Receiving ezetimibe treatment 3. Over 12 years of age (no maximum) 4. Concomitant illnesses or conditions 1. Pregnancy 2. Intellectual disability 3. Bowel or biliary obstruction 4. Known hypersensitivity to colesevelam or any ingredients of colesevelam</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>plant sterols</keyword>
	<keyword>cholesterol</keyword>
	<keyword>colesevelam</keyword>
	<keyword>phytosterolemia</keyword>
	<keyword>fish oil</keyword>
</DOC>